Implantation of Cardioverter-Defibrillator in Children With Long-QT Syndrome: Assessment of Indications, Efficacy, and Safety Based on 10-Year Experience

Purpose: to assess specificities of course of the long­QT syndrome in children before and after implantation of cardioverter­defibrillator (ICD), and optimization of indications to ICD­therapy.

Materials and methods. We included in this study 48 children with long­QT syndrome from 44 unrelated families (28 boys and 20 girls), who underwent ICD implantation at the mean age 11.8±3.8 years. Mean duration of follow­up after implantation was 5.2±2.8 years. Data from these children were compared with those from 59 children of comparable age and gender with long­QT syndrome from 46 unrelated families receiving antiarrhythmic therapy (β­adrenoblockers). We assessed clinical and electrocardiographic characteristics of the disease obtained at initial visit and their dynamics thereafter.

Results. Children with long­QT syndrome and ICD were mainly probands with interval QT longer than 500 ms, recurrent syncope and often history of sudden cardiac arrest requiring high doses of β­adrenoblockers for control of ventricular tachyarrhythmias.

Conclusion. ICD implantation is an effective and safe method both of primary and secondary prevention of sudden cardiac death in children with long­QT syndrome.

1. Schwartz P.J., Crotti L., Insolia R. Long-QT syndrome: from genetics to management. Circulation 2012;5 (4):868-877. DOI: 10.1161/CIRCEP.111.962019

2. Fuster V., Walsh R. A., Harrington R. A. et al. Genetics of chan-nelopathies and clinical implications. In: Fuster V., Walsh R. A., Harrington R. A. eds. Hurst's The Heart. 13th ed. New York, NY: McGraw Hill 2011:897-910.

3. Napolitano C., Bloise R., Monteforte N., Priori S. G. Sudden cardiac death and genetic ion channelopathies long QT, Brugada, short QT, catecholaminergic polymorphic ventricular tachycardia, and idiopathic ventricular fibrillation. Circulation 2012;125:2027-2034. DOI: 10.1161/CIRCULATIONAHA.111.055947

4. Tester D.J., Ackerman M.J. Genetics of long QT syndrome. Methodist Debakey Cardiovasc J 2014;10 (1):29-33.

5. Schwartz P.J., Stramba-Badiale M., Crotti L. et al. Prevalence of the Congenital Long QT Syndrome. Circulation 2009; 120 (18):1761-1767.

6. Priori S. G., Schwartz P.J., Napolitano C. et al. Risk stratification in the long QT syndrome. N Engl J Med 2003;348:1866-1874. DOI: 10.1056/NEJMoa022147

7. Hobbs J. B., Peterson D. R., Moss A.J. et al. Risk of aborted cardiac arrest or sudden cardiac death during adolescence in the long-QT syndrome. JAMA 2006;296:1249-1254. DOI: 10.1001/jama.296.10.1249

8. Berul C. I. Congenital long QT syndromes: who's at the risk for sudden cardiac death? Circulation 2008;117:2178-2180. DOI: 10.1161/CIRCULATIONAHA.108.772053

9. Moss A.J., Schwartz P.J. Sudden death and idiopathic long QT syndrome. Am J Med 1979;66:6-7.

10. Moss A.J., Zareba W., Hall W.J. et al. Effectiveness and limitations of beta-blocker therapy in congenital long QT syndrome. Circulation 2000;101:616-623.

11. Barsheshet A., Goldenberg I., O-Uchi J. et al. Mutations in cytoplasmic loops of the KCNQ1 channel and the risk of life-threatening events: implications for mutation-specific response to beta-blocker therapy in type 1 long-QT syndrome. Circulation 2012;125:1988-1996. DOI: 10.1161/CIRCULATIONAHA.111.048041

12. Chatrath R., Bell C. M., Ackerman M.J. Beta-blocker therapy failures in symptomatic probands with genotyped long-QT syndrome. Pediatr Cardiol 2004;25:459-465. DOI: 10.1007/s00246-003-0567-3

13. Wu J., Naiki N., Ding W. G. et al. A molecular mechanism for adrenergic-induced long QT syndrome. J Am Coll Cardiol 2014;63:819-827. DOI: 10.1016/j.jacc.2013.08.1648

14. Schwartz P.J., Spazzolini C., Crotti L. et al. The Jervell and Lange-Nielsen syndrome. Natural history, molecular basis, and clinical outcome. Circulation 2006;113:783-790. DOI: 10.1161/CIRCULATIONAHA.105.592899

15. Mullally J., Goldenberg I., Moss A. J. et al. Risk of life-threatening cardiac events among patients with long QT syndrome and multiple mutations. Heart Rhythm 2013;10 (3):378-382. DOI: 10.1016/j.hrthm.2012.11.006

16. Groh W.J., Silka M.J., Oliver R. P. et al. Use of implantable cardioverter-defibrillators in the congenital long QT syndrome. Am J Cardiol 1996;75:703-706.

17. Schwartz P.J., Spazzolini C., Priori S. G. et al. Who Are the Long-QT Syndrome Patients Who Receive an Implantable Cardioverter-Defibrillator and What Happens to Them? Data From the European Long-QT Syndrome Implantable Cardioverter-Defibrillator (LQTS ICD) Registry. Circulation 2010;122:1272-1282. DOI: 10.1161/CIRCULATIONAHA.110.950147

18. Horner J. M., Kinoshita M., Webster T. L. et al. Implantable cardioverter defibrillator therapy for congenital long QT syndrome: a single-center experience. Heart Rhythm 2010;7 (11):1616-1622. DOI: http://dx.doi.org/10.1016/j.hrthm.2010.08.023

19. HRS / EHRA / APHRSExpert Consensus Statement on the Diagnosis and Management of Patients with Inherited Primary Arrhythmia Syndromes. Heart Rhythm 2013;10:1932-1963. DOI: 10.1016/j.hrthm.2013.05.014

20. Silka M.J., Kron J., Dunnigan A., Dick M. Sudden cardiac death and the use of implantable cardioverter-defibrillators in pediatric patients. The Pediatric Electrophysiology Society. Circulation 1993;87:800-807.

21. Schwartz P.J., Spazzolini C., Crotti L. All LQT3 patients need an ICD: true or false? Heart Rhythm 2009;6 (1):113-120.

22. Goel A. K., Berger S., Pelech A., Dhala A. Implantable cardioverter defibrillator therapy in children with long QT syndrome. Pediatr Cardiol 2004;25 (4):370-378. DOI: 10.1007/s00246-003-0566-4.

23. Zareba W., Moss A. J., Daubert J. P. et al. Implantable cardioverter defibrillator in high-risk long QT syndrome patients. J Cardiovasc Electrophysiol 2003;14 (4):337-341.

24. Locati E. H., Zareba W., Moss A.J. et al. Age- and Sex-related differences in clinical manifestation in patients with congenital long QT syndrome: findings from International LQTS Registry. Circulation 1998;97:2237-2244.

25. Vink A. S., Clur S. B., Wilde A. A. M., Blom N. A. Effect of age and gender on the QTc-interval in healthy individuals and patients with Long-QT syndrome. Trends Cardiovasc Med 2017; pii: S1050-1738 (17) 30116-0. DOI: 10.1016/j.tcm.2017.07.012